Bridgebio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil sold 10,000 Bridgebio Pharma, Inc. shares (Form 4)

Traded Sep 17, 2026 · Filed Sep 21, 2026

On Sep 17, 2026, Kumar Neil (Director, Chief Executive Officer) sold 10,000 Bridgebio Pharma, Inc. shares at an average US$69.08 for US$691K under a trading plan, leaving 495,686 shares. Filed Sep 21, 2026 (Form 4).

Sold
10,000 shares
Price
US$69.08 average (US$69.01 to US$69.57)
Value
US$691K
Holding after
495,686 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 17, 2026Common StockSale8,721US$69.01496,965Indirect
Sep 17, 2026Common StockSale1,279US$69.57495,686Indirect

Source

View original at SEC

Related